Answers are grounded in this paper and cite their sources.
Though the underlying pathophysiology of Coronavirus disease is not fully understood, several reports suggest that coagulopathy plays a vital role in severity and outcome. On admission, an elevated coagulation profile had a significant impact on overall survival and morbidity. This is a multi-centre observational study. The objective of this study is to characterize the on-admission coagulation profiles of hospitalized subjects with COVID-19. A total of 355 hospitalized subjects with COVID-19 were recruited for this study from 4 dedicated COVID hospitals in Dhaka and outside of Dhaka. Along with other investigations, we do routine coagulation profiles for our study, which include prothrombin time, activated partial thromboplastin time and D-dimer level. Among 355 patients, coagulation profiles can be done in 229 patients. The death rate among the hospitalized COVID-19 patients was very low, 0.3% only. Mean PT was 15±1, mean APTT was 36±1, mean D-dimer was o.887±0.127 and coagulopathy developed in 19% cases. Ground glass opacity was not found in mild COVID-19 cases but 17 severe cases had ground glass opacity, 105 mild cases and 29 moderate cases had bilateral consolidation on radiological evaluation. There is a scarcity of data in Bangladesh regarding coagulopathy assessment of hospitalized subjects with COVID-19. Further studies are necessary to determine whether coagulopathy is associated with a higher morbidity and mortality rate in COVID-19 patients.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: